Huge scope for Indian pharma as FDA eases drug scrutiny over shortage in US

Most visited

1 year ago full article

share

Injectibles account for 60% of crunch; most plants under American regulator's lens the past two months have now received positive outcomes ...Read More

260o

80%
Menu

Leave a Comment